Clinical Trials Directory

Trials / Completed

CompletedNCT00979199

Evaluation of Integrated Cardiac Imaging in Ischemic Heart Disease

Evaluation of Integrated Cardiac Imaging for the Detection and Characterization of Ischemic Heart Disease

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
697 (actual)
Sponsor
Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy · Other Government
Sex
All
Age
30 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Main purpose of the study: To comparatively assess the diagnostic performance of non invasive anatomical and functional imaging modalities to detect significant obstructive coronary artery disease as demonstrated at invasive coronary angiography and functional evaluation of coronary lesions (fractional flow reserve).

Detailed description

Objectives of the study 1. To test the accuracy of anatomical and functional non-invasive cardiac imaging in the diagnosis of IHD. To this purpose the "anatomical" information provided by CTA is obtained in every patient together with the "functional" information provided by stress radionuclide cardiac imaging (SPECT or PET), to assess myocardial perfusion, and/or by stress MRI or ECHO imaging to assess myocardial contraction. Non-invasive results are tested against invasive reference standards. The latter consists of invasive coronary angiography integrated by invasive measurement of fractional flow reserve (to assess the hemodynamic relevance of intermediate coronary stenoses). 2. To test the accuracy of integrated models, including clinical variables, risk factors and circulating biomarkers, to predict significant obstructive coronary artery disease in patients with chronic angina-like symptoms. To correlate biohumoral profiles with the coronary anatomical-functional phenotype as obtained by non invasive imaging in the same patients. To reach these goals the clinical characterization of patients (collected before non-invasive imaging) and the laboratory characterization (that includes novel biomarkers of cardiovascular risk) are compared with patient characterization derived from non invasive "anatomic-functional" imaging and with invasive diagnosis of significantly obstructive coronary disease. 3. To develop an advanced clinical and imaging reporting tool in cardiology. An informatics platform is developed to synthetically and clearly present the integrated clinical and imaging diagnostic profile of individual patients. A multimodal imaging reporting tool is developed including tools for "image fusion" of different imaging modalities (CT, SPECT, PET, MRI). 4. To define the most cost-effective work-up for the diagnosis and characterization of IHD. To this purpose the costs and the procedural risks (including radiation exposure) of non-invasive and invasive diagnostic procedures are prospectively collected. Cost-benefit and cost-effectiveness analyses is conducted alongside the EVINCI-study clinical trial.

Conditions

Interventions

TypeNameDescription
OTHERNon invasive cardiac imagingNon invasive cardiac imaging consists of CTCA combined with one Stress Imaging Test

Timeline

Start date
2009-02-01
Primary completion
2010-07-01
Completion
2012-06-01
First posted
2009-09-17
Last updated
2014-07-21
Results posted
2014-07-21

Locations

16 sites across 9 countries: Finland, France, Germany, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom

Source: ClinicalTrials.gov record NCT00979199. Inclusion in this directory is not an endorsement.